Greenwich LifeSciences (GLSI) Institutional Ownership $9.56 -0.07 (-0.73%) As of 11:17 AM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Greenwich LifeSciences (NASDAQ:GLSI)CurrentInstitutional OwnershipPercentage4.16%Number ofInstitutional Buyers(last 12 months)15TotalInstitutional Inflows(last 12 months)$1.90MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$138.78K Get GLSI Insider Trade Alerts Want to know when executives and insiders are buying or selling Greenwich LifeSciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data GLSI Institutional Buying and Selling by Quarter Greenwich LifeSciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/29/2025 Rhumbline Advisers9,673$92K0.0%+48.7%0.072% 5/28/2025 Strs Ohio18,600$177K0.0%N/A0.139% 5/13/2025 HighTower Advisors LLC15,407$147K0.0%N/A0.116% 5/9/2025 Charles Schwab Investment Management Inc.19,007$181K0.0%+15.5%0.143% 4/8/2025 Rhumbline Advisers9,673$92K0.0%+48.7%0.074% 4/7/2025 GAMMA Investing LLC1,202$126K0.0%N/A0.009% 2/17/2025 Bank of America Corp DE7,262$82K0.0%+22.3%0.055% 2/14/2025 Northern Trust Corp87,423$982K0.0%+17.3%0.665% 2/13/2025 Barclays PLC9,648$108K0.0%+12.7%0.073% 2/13/2025 Renaissance Technologies LLC22,700$255K0.0%-30.2%0.173% Get the Latest News and Ratings for GLSI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Greenwich LifeSciences and its competitors with MarketBeat's FREE daily newsletter. 2/13/2025 Wells Fargo & Company MN2,847$32K0.0%+54.8%0.022% 2/12/2025 Brown Brothers Harriman & Co.4,000$45K0.0%N/A0.030% 2/12/2025 JPMorgan Chase & Co.7,061$79K0.0%+172.0%0.054% 12/10/2024 Garden State Investment Advisory Services LLC17,600$253K0.1%N/A0.134% 11/19/2024 Barclays PLC8,560$123K0.0%+323.3%0.065% 11/16/2024 Geode Capital Management LLC133,550$1.92M0.0%+4.6%1.016% 11/15/2024 Barclays PLC8,560$123K0.0%+323.3%0.065% 11/15/2024 State Street Corp71,408$1.03M0.0%+4.4%0.543% 11/15/2024 Garden State Investment Advisory Services LLC17,600$253K0.1%N/A0.134% 11/12/2024 Charles Schwab Investment Management Inc.16,455$236K0.0%-10.8%0.125% 8/1/2024 Rhumbline Advisers6,799$117K0.0%N/A0.053% 7/26/2024 Bank of New York Mellon Corp15,295$264K0.0%N/A0.119% 5/10/2024 Vanguard Group Inc.223,102$4.45M0.0%+0.6%1.732% 2/14/2023 683 Capital Management LLC11,700$178K0.0%N/A0.091% 11/15/2022 Pura Vida Investments LLC19,667$179K0.0%N/A0.153% 8/8/2022 Walleye Capital LLC10,656$90K0.0%N/A0.082% 4/29/2022 Nisa Investment Advisors LLC7,200$141K0.0%N/A0.056% 2/7/2022 SG Americas Securities LLC4,395$107K0.0%N/A0.034% 11/15/2021 Invesco Ltd.148,087$5.79M0.0%-47.1%1.138% 11/15/2021Tibra Equities Europe Ltd12,700$496K0.8%N/A0.098% 11/12/2021 OLD Mission Capital LLC7,358$287K0.0%N/A0.057% 11/12/2021 Geode Capital Management LLC56,919$2.22M0.0%+8.6%0.437% 8/17/2021 Invesco Ltd.280,062$12.59M0.0%N/A2.171% 8/16/2021 California State Teachers Retirement System5,588$251K0.0%N/A0.043% 8/16/2021 Charles Schwab Investment Management Inc.9,819$442K0.0%N/A0.076% 8/16/2021 State Street Corp50,212$2.26M0.0%N/A0.389% 8/16/2021Nuveen Asset Management LLC6,392$287K0.0%N/A0.050% 8/13/2021 Northern Trust Corp12,098$544K0.0%N/A0.094% 8/13/2021 Geode Capital Management LLC52,395$2.35M0.0%+262.3%0.406% 8/13/2021 Vanguard Group Inc.121,418$5.46M0.0%+14.3%0.941% Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad)Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape. For the moment, you can watch this interview free of charge – just click here.8/12/2021 State of Wisconsin Investment Board5,200$234K0.0%N/A0.040% 8/12/2021 JPMorgan Chase & Co.4,789$216K0.0%N/A0.037% 8/11/2021 Bank of New York Mellon Corp6,664$300K0.0%N/A0.052% 8/11/2021BlackRock Inc.217,748$9.79M0.0%+242.7%1.688% 8/11/2021 Deutsche Bank AG2,396$108K0.0%N/A0.019% 8/10/2021 Citigroup Inc.1,611$72K0.0%+212.8%0.012% 8/2/2021 New York State Common Retirement Fund3,500$157K0.0%N/A0.027% 5/18/2021 Millennium Management LLC19,450$663K0.0%+169.7%0.000% 5/18/2021 Citadel Advisors LLC7,114$243K0.0%N/A0.000% 5/17/2021 Royal Bank of Canada2,800$95K0.0%N/A0.000% 5/17/2021 HRT Financial LP10,952$373K0.0%N/A0.000% 5/12/2021 Geode Capital Management LLC14,463$493K0.0%+106.0%0.000% 5/7/2021BlackRock Inc.63,540$2.17M0.0%+7.2%0.000% (Data available from 1/1/2016 forward) GLSI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GLSI shares? During the previous two years, 17 institutional investors and hedge funds held shares of Greenwich LifeSciences. The most heavily invested institutionals were Vanguard Group Inc. ($4.45M), Geode Capital Management LLC ($1.92M), State Street Corp ($1.03M), Northern Trust Corp ($982K), Bank of New York Mellon Corp ($264K), Renaissance Technologies LLC ($255K), and Garden State Investment Advisory Services LLC ($253K).Learn more on GLSI's institutional investors. What percentage of Greenwich LifeSciences stock is owned by institutional investors? 4.16% of Greenwich LifeSciences stock is owned by institutional investors. Learn more on GLSI's institutional investor holdings. Which institutional investors have been buying Greenwich LifeSciences stock? Of the 16 institutional investors that purchased Greenwich LifeSciences stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Garden State Investment Advisory Services LLC ($35.20K), Strs Ohio ($18.60K), HighTower Advisors LLC ($15.41K), Bank of New York Mellon Corp ($15.30K), Barclays PLC ($14.16K), Rhumbline Advisers ($13.14K), and Northern Trust Corp ($12.92K). How much institutional buying is happening at Greenwich LifeSciences? Institutional investors have bought a total of 149,559 shares in the last 24 months. This purchase volume represents approximately $1.93M in transactions. Which Greenwich LifeSciences major shareholders have been selling company stock? The following institutional investors have sold Greenwich LifeSciences stock in the last 24 months: Renaissance Technologies LLC ($9.80K), and Charles Schwab Investment Management Inc. ($2.00K). How much institutional selling is happening at Greenwich LifeSciences? Institutional investors have sold a total of 11,799 shares in the last 24 months. This volume of shares sold represents approximately $138.78K in transactions. Related Companies ZVRA Institutional Ownership ABVX Institutional Ownership ATYR Institutional Ownership TRML Institutional Ownership AMLX Institutional Ownership ALT Institutional Ownership RGNX Institutional Ownership ORKA Institutional Ownership RAPP Institutional Ownership ERAS Institutional Ownership This page (NASDAQ:GLSI) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredBillionaires are piling into this gold investmentBillionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scra...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Greenwich LifeSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Greenwich LifeSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.